Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?

Urological research - 1 Dec 2004

Malviya Vibhav, Singh Harbans, Dwivedi U S, Usha, Singh P B

Abstract excerpt

The aim of this study was to find the correlation between serum p53 and carcinoma of the bladder and to investigate whether serum p53 protein can be used as a tumor marker for p53 gene alteration. The study included patients with carcinoma of the bladder and controls. Serum p53 protein estimation was done with an ELISA kit. There were 23 patients with superficial and 17 with invasive carcinoma. The median serum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 15503000
DOI: 10.1007/s00240-004-0415-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?PMID 15503000Read ↗

[Gene p53 mutation and prognosis in bladder tumors].Semantic proximity Read ↗

The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer.Semantic proximity Read ↗

Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.Semantic proximity Read ↗

Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.Semantic proximity Read ↗

[Is protein p53 an independent prognostic factor in bladder carcinoma?].Semantic proximity Read ↗

[Usefulness of p53 in the clinical management of bladder tumors].Semantic proximity Read ↗

Can molecular markers now be used for early diagnosis of malignancy?Semantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

p53 and treatment of bladder cancer.Semantic proximity Read ↗

p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay.Semantic proximity Read ↗

P53 mutations in urinary bladder cancer patients from Central Poland.Semantic proximity Read ↗

Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.